Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lord's Mark Industries has informed that it attached the intimation titled ‘Technical Committee Approves Final Clinical Trial Stage; Company Targets Regulatory Clearances and Commercial Launch by April 2027’.
The above information is a part of company’s filings submitted to BSE.